SOVALDI™ (sofosbuvir) approved by Health Canada

Sofosbuvir (trade name Sovaldi) has now been approved for use in Canada. There will still be many months before it is approved for coverage by your provincial Pharmacare plan. But meanwhile, if you are in great need of this drug but fear you cannot afford it, consider applying to Gilead Sciences compassionate care's Momentum Support Program™ or their Sovaldi Co-pay assistance program. See details in complete Gilead Sciences Press Release below. ###  HEALTH

GALEXOS™ (simeprevir) approved by Health Canada

Simeprevir (trade name Galexos) has now been approved for use in Canada. It is a once-daily pill which is taken along with ribavirin and pegylated interferon alfa to treat hepatitis C genotype 1 in a "triple therapy."  There will still be many months before it is approved for coverage by your provincial Pharmacare plan. See details in complete Janssen Inc. Press Release below. ### New Treatment for Hepatitis C Approved by Health Canada Priority Review Give